Literature DB >> 7599602

Topical application of a corticosteroid destabilizes the host-parasite relationship in an experimental model of the oral carrier state of Candida albicans.

N Deslauriers1, C Coulombe, B Carré, J P Goulet.   

Abstract

Using an experimental model in the mouse we have shown that both local and central lines of defense, involving CD4+ T cells, participate in a dynamic interaction to maintain a long-term carrier state of Candida albicans in the oral cavity. We have tested the impact of a predisposing factor to oral candidiasis in the form of a topical application of a corticosteroid (Topsyn gel) to the oral mucosa for 75 mice twice a day for a 20-day period. Very rapidly after the treatment was initiated, i.e. on day 4, the residual population of Candida increased up to 40-fold and by day 21, the population was 400-fold that of the carrier state. The resident population of intraepithelial CD4+ T cells in the oral mucosa virtually disappeared during the treatment. A topical corticosteroid application also resulted in a massive depletion of T cells in the lymph nodes and in the transient abrogation of the DTH reaction to Candida antigens. On cessation of treatment, normal levels of both Candida and intraepithelial CD4+ T cells were also quickly restored. These results suggest that resistance to superficial invasion by Candida is linked to the presence of an oral mucosal line of defense and that topical application of corticosteroids may dramatically shift the host-parasite relationship in favor of Candida.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599602     DOI: 10.1111/j.1574-695X.1995.tb00077.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  9 in total

Review 1.  Experimental oral candidiasis in animal models.

Authors:  Y H Samaranayake; L P Samaranayake
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions.

Authors:  Durdana Rahman; Mukesh Mistry; Selvam Thavaraj; Stephen J Challacombe; Julian R Naglik
Journal:  Microbes Infect       Date:  2007-01-27       Impact factor: 2.700

3.  Oral carriage of Candida albicans in murine AIDS.

Authors:  N Deslauriers; L Côté; S Montplaisir; L de Repentigny
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

Review 4.  IL-12 and related cytokines: function and regulatory implications in Candida albicans infection.

Authors:  Robert B Ashman; Dipti Vijayan; Christine A Wells
Journal:  Clin Dev Immunol       Date:  2010-11-01

5.  A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia.

Authors:  P P Dwivedi; S Mallya; A Dongari-Bagtzoglou
Journal:  Med Mycol       Date:  2008-06-10       Impact factor: 4.076

Review 6.  Animal models of mucosal Candida infection.

Authors:  Julian R Naglik; Paul L Fidel; Frank C Odds
Journal:  FEMS Microbiol Lett       Date:  2008-04-16       Impact factor: 2.742

7.  Farnesol, a fungal quorum-sensing molecule triggers Candida albicans morphological changes by downregulating the expression of different secreted aspartyl proteinase genes.

Authors:  Nadège Décanis; Neftaha Tazi; Alexandra Correia; Manuel Vilanova; Mahmoud Rouabhia
Journal:  Open Microbiol J       Date:  2011-11-18

8.  Analysis of the influence of parenteral cancer chemotherapy on the health condition of oral mucosa.

Authors:  Mansur Rahnama; Barbara Madej-Czerwonka; Izabela Jastrzębska-Jamrogiewicz; Rafał Jamrogiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2015-03-26

9.  Medium-Chain Fatty Acids Released from Polymeric Electrospun Patches Inhibit Candida albicans Growth and Reduce the Biofilm Viability.

Authors:  Katharina H Clitherow; Tahani M Binaljadm; Jens Hansen; Sebastian G Spain; Paul V Hatton; Craig Murdoch
Journal:  ACS Biomater Sci Eng       Date:  2020-05-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.